These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8974209)

  • 21. Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
    Loehberg CR; Jud SM; Haeberle L; Heusinger K; Dilbat G; Hein A; Rauh C; Dall P; Rix N; Heinrich S; Buchholz S; Lex B; Reichler B; Adamietz B; Schulz-Wendtland R; Beckmann MW; Fasching PA
    Breast Cancer Res Treat; 2010 May; 121(1):101-10. PubMed ID: 20306293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early development of cancer chemoprevention clinical trials: studies of dietary calcium as a chemopreventive agent for human subjects.
    Lipkin M
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S65-70. PubMed ID: 12570337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.
    Jenkins RA; Chinaworapong S; Morgan PA; Ruangyuttikarn C; Sontirat A; Chiu J; Michael RA; Nitayaphan S; Khamboonruang C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):171-7. PubMed ID: 9637582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recruitment and Retention in Clinical Trials of Deep Brain Stimulation in Early-Stage Parkinson's Disease: Past Experiences and Future Considerations.
    Grace Cannard K; Hacker ML; Molinari A; Heusinkveld LE; Currie AD; Charles D
    J Parkinsons Dis; 2018; 8(3):421-428. PubMed ID: 30010145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptions of a community sample about participation in future HIV vaccine trials in south India.
    Nyamathi AM; Suhadev M; Swaminathan S; Fahey JL
    AIDS Behav; 2007 Jul; 11(4):619-27. PubMed ID: 17016758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.
    Bleidorn J; Bucak S; Gágyor I; Hummers-Pradier E; Dierks ML
    Ger Med Sci; 2015; 13():Doc17. PubMed ID: 26512232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SECONDARY HYPERPARATHYROIDISM AFTER BARIATRIC SURGERY: TREATMENT IS WITH CALCIUM CARBONATE OR CALCIUM CITRATE?
    Baretta GA; Cambi MP; Rodrigues AL; Mendes SA
    Arq Bras Cir Dig; 2015; 28 Suppl 1(Suppl 1):43-5. PubMed ID: 26537273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D supplementation for prevention of cancer in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007469. PubMed ID: 24953955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "I will miss the study, God bless you all": participation in a nutritional chemoprevention trial.
    Moreno-Black G; Shor-Posner G; Miguez MJ; Burbano X; O'Mellan S; Yovanoff P
    Ethn Dis; 2004; 14(4):469-75. PubMed ID: 15724764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.
    Ding EL; Powe NR; Manson JE; Sherber NS; Braunstein JB
    Arch Intern Med; 2007 May; 167(9):905-12. PubMed ID: 17502531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.
    Brown JC; Troxel AB; Ky B; Damjanov N; Zemel BS; Rickels MR; Rhim AD; Rustgi AK; Courneya KS; Schmitz KH
    Contemp Clin Trials; 2016 Mar; 47():366-75. PubMed ID: 26970181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large bowel adenomas: markers of risk and endpoints.
    Baron JA
    J Cell Biochem Suppl; 1996; 25():142-8. PubMed ID: 9027611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between participants and nonparticipants in an exercise trial for adults with rheumatoid arthritis.
    de Jong Z; Munneke M; Jansen LM; Ronday K; van Schaardenburg DJ; Brand R; van den Ende CH; Vliet Vlieland TP; Zuijderduin WM; Hazes JM
    Arthritis Rheum; 2004 Aug; 51(4):593-600. PubMed ID: 15334432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a model predicting enrollment status in a chemoprevention trial for breast cancer.
    Yeomans Kinney A; Vernon SW; Shui W; Weber DV; Schell M; Vogel VG
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):591-5. PubMed ID: 9681527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I trials in cancer patients: participants' perceptions.
    Hutchison C
    Eur J Cancer Care (Engl); 1998 Mar; 7(1):15-22. PubMed ID: 9582747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer prevention in community clinics: will low-income Latina patients participate in clinical trials?
    Mandelblatt J; Kaufman E; Sheppard VB; Pomeroy J; Kavanaugh J; Canar J; Pallandre L; Cullen J; Huerta E
    Prev Med; 2005 Jun; 40(6):611-8. PubMed ID: 15850856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Willingness to participate in complementary and alternative medicine clinical trials among patients with craniofacial disorders.
    Schneider J; Vuckovic N; DeBar L
    J Altern Complement Med; 2003 Jun; 9(3):389-401. PubMed ID: 12816627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
    Meropol NJ; Weinfurt KP; Burnett CB; Balshem A; Benson AB; Castel L; Corbett S; Diefenbach M; Gaskin D; Li Y; Manne S; Marshall J; Rowland JH; Slater E; Sulmasy DP; Van Echo D; Washington S; Schulman KA
    J Clin Oncol; 2003 Jul; 21(13):2589-96. PubMed ID: 12829680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.